Search results
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
Zacks via Yahoo Finance· 2 weeks agoAstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra...
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra...
AstraZeneca drug fails one main goal in study of chronic immune disease
Reuters via Yahoo News· 1 year agoThe condition, eosinophilic esophagitis, is characterised by inflammation and damage to the...
Pennsylvania woman stunned to be charged $50K for asthma medication. No one can explain it
USA TODAY via Yahoo News· 2 years agoYORK, Pa. — Jessica Eckard has always had asthma problems. Her father died of tuberculosis when she...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 1 year agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo
Zacks via Yahoo Finance· 7 months agoData from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut...
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Zacks via Yahoo Finance· 2 weeks agoThis week, J&J JNJ proposed to buy medical device company Shockwave Medical SWAV for approximately...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 7 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
What Is Severe Asthma?
Health via Yahoo News· 3 weeks agoRealPeopleGroup / Getty Images Medically reviewed by Reza Samad, MD Severe asthma is the term used for asthma that is difficult to treat and control....
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Zacks via Yahoo Finance· 1 year agoRegeneron's (REGN) share price rose after it reported data from a late-stage study showing that...